Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2013

01-02-2013 | Clinical Trial

The association of preoperative breast magnetic resonance imaging and multiple breast surgeries among older women with early stage breast cancer

Authors: Shi-Yi Wang, Karen M. Kuntz, Todd M. Tuttle, David R. Jacobs Jr., Robert L. Kane, Beth A. Virnig

Published in: Breast Cancer Research and Treatment | Issue 1/2013

Login to get access

Abstract

To evaluate the association between preoperative breast magnetic resonance imaging (MRI) utilization and the rate of multiple surgeries, and to investigate the extent of any variation of rates of multiple surgeries among physicians. We identified patients with stage 0, I, or II breast cancer diagnosed between 2002 and 2007 in the Surveillance, Epidemiology, and End Results-Medicare database. Using diagnosis and procedure codes, we defined that the initial treatment episode had ended when a gap in surgery occurred at least 90 days after primary surgery. Surgical procedures of partial mastectomy or mastectomy during the initial treatment period were calculated to identify patients who received multiple surgeries. Multilevel logistic regression models were used to identify patient- and physician-level predictors of multiple surgeries. Of 45,453 women with early stage breast cancer who were treated by 2,595 surgeons during the study period, 9,462 patients (20.8 %) received multiple breast surgeries; of these patients, 8,318 (87.9 %) underwent one additional surgery, 988 (10.4 %) received two additional surgeries, and 156 (1.6 %) received three or more additional surgeries. Among 2,997 (6.6 % of the entire cohort) women who underwent preoperative breast MRI evaluation, 770 received multiple breast surgeries. After we adjusted for patient and tumor characteristics associated with multiple surgeries, we found that the rate of multiple surgeries was not significantly different between the two groups with or without preoperative breast MRI. Furthermore, the median odds ratio of 2.0, corresponding with the median value of the relative odds of receiving multiple surgeries between two randomly chosen physicians after controlling for other confounders, indicated a large individual surgeon effect. Substantial variation was observed in the rates of multiple surgeries in women aged 66 and older with early stage breast cancer. Evidence does not support that preoperative breast MRI reduces the incidence of multiple surgeries.
Literature
1.
Lee MC, Rogers K, Griffith K et al (2009) Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J 15(1):34–40PubMedCrossRef
2.
McCahill LE, Single RM, Aiello Bowles EJ et al (2012) Variability in reexcision following breast conservation surgery. JAMA 307(5):467–475PubMedCrossRef
3.
Kotwall C, Ranson M, Stiles A et al (2007) Relationship between initial margin status for invasive breast cancer and residual carcinoma after re-excision. Am Surg 73(4):337–343PubMed
4.
Waljee JF, Hu ES, Newman LA et al (2008) Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol 15(5):1297–1303PubMedCrossRef
5.
Menes TS, Tartter PI, Bleiweiss I et al (2005) The consequence of multiple re-excisions to obtain clear lumpectomy margins in breast cancer patients. Ann Surg Oncol 12(11):881–885PubMedCrossRef
6.
Morrow M, Jagsi R, Alderman AK et al (2009) Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 302(14):1551–1556PubMedCrossRef
7.
Cellini C, Hollenbeck ST, Christos P et al (2004) Factors associated with residual breast cancer after reexcision for close or positive margins. Ann Surg Oncol 11(10):915–920PubMedCrossRef
8.
Subhas G, Shah AJ, Gupta A et al (2011) Review of third and fourth re-excision for narrow or positive margins of invasive and intraductal carcinoma. Int Surg 96(1):18–20PubMedCrossRef
9.
Wang SY, Virnig BA, Tuttle TM et al (2012) Variability of preoperative breast MRI utilization among older women with newly diagnosed early-stage breast cancer. Breast J (in press)
10.
Lehman CD, DeMartini W, Anderson BO et al (2009) Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw 7:193–201PubMed
11.
Hwang N, Schiller DE, Crystal P et al (2009) Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol 16(11):3000–3009PubMedCrossRef
12.
Bleicher RJ, Ciocca RM, Egleston BL et al (2009) The association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 209(2):180–187PubMedCrossRef
13.
Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571PubMedCrossRef
14.
Houssami N, Ciatto S, Macaskill P et al (2008) Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26(19):3248–3258PubMedCrossRef
15.
Vanderwalde LH, Dang CM, Bresee C et al (2011) Discordance between pathologic and radiologic tumor size on breast MRI may contribute to increased re-excision rates. Am Surg 77(10):1361–1363PubMed
16.
Blair SL, Thompson K, Rococco J et al (2009) Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J Am Coll Surg 209(5):608–613PubMedCrossRef
17.
Azu M, Abrahamse P, Katz SJ et al (2010) What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol 17(2):558–563PubMedCrossRef
18.
19.
Bach PB, Guadagnoli E, Schrag D et al (2002) Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40(8 Suppl IV):19–25
20.
Friese CR, Neville BA, Edge SB et al (2009) Breast biopsy patterns and outcomes in Surveillance, Epidemiology, and End Results-Medicare data. Cancer 115(4):716–724PubMedCrossRef
21.
Klabunde CN, Warren JL, Legler JM (2002) Assessing comorbidity using claims data: an overview. Med Care 40(8 Suppl IV):26–35
22.
Baldwin LM, Adamache W, Klabunde CN et al (2002) Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care 40(8 Suppl IV):82–95
23.
Larsen K, Merlo J (2005) Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol 161:81–88PubMedCrossRef
24.
Miller BT, Abbott AM, Tuttle TM (2011) The influence of preoperative MRI on breast cancer treatment. Ann Surg Oncol, e-pub ahead of print
25.
Pengel KE, Loo CE, Teertstra HJ et al (2008) The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat 116(1):161–169PubMedCrossRef
26.
Mann RM, Loo CE, Wobbes T et al (2010) The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 119(2):415–422PubMedCrossRef
27.
Brennan ME, Houssami N, Lord S et al (2009) Magnetic resonance imaging screening of the contralateral breast in women with newly diagnosed breast cancer: systematic review and meta-analysis of incremental cancer detection and impact on surgical management. J Clin Oncol 27(33):5640–5649PubMedCrossRef
28.
Desch CE, McNiff KK, Schneider EC et al (2008) American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol 26(21):3631–3637PubMedCrossRef
29.
Talsma AK, Reedijk AM, Damhuis RA et al (2011) Re-resection rates after breast-conserving surgery as a performance indicator: introduction of a case-mix model to allow comparison between Dutch hospitals. Eur J Surg Oncol 37(4):357–363PubMedCrossRef
30.
Yeh ED (2010) Breast magnetic resonance imaging: Current clinical indications. Magn Reson Imaging Clin N Am 18(2):155–169, vii
31.
Morrow M, Freedman G (2006) A clinical oncology perspective on the use of breast MR. Magn Reson Imaging Clin N Am 14(3):363–78, vi
32.
Orel SG, Reynolds C, Schnall MD et al (1997) Breast carcinoma: MR imaging before re-excisional biopsy. Radiology 205(2):429–436PubMed
Metadata
Title
The association of preoperative breast magnetic resonance imaging and multiple breast surgeries among older women with early stage breast cancer
Authors
Shi-Yi Wang
Karen M. Kuntz
Todd M. Tuttle
David R. Jacobs Jr.
Robert L. Kane
Beth A. Virnig
Publication date
01-02-2013
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2013
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-013-2420-6

Other articles of this Issue 1/2013

Breast Cancer Research and Treatment 1/2013 Go to the issue

Preclinical study

Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic

Clinical Trial

Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer

Epidemiology

Involvement of early growth response factors in TNFα-induced aromatase expression in breast adipose

Epidemiology

Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?

Clinical trial

Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology

Preclinical study

Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits